DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» CIITA
CIITA
CIITA Stimulation of Transcription Factor Binding to Major Histocompatibility Complex Class II and Associated Promoters in Vivo
Significant Shortest Paths for the Detection of Putative Disease Modules
ATP-Binding and Hydrolysis in Inflammasome Activation
A Role for the Nlr Family Members Nlrc4 and Nlrp3 in Astrocytic Inflammasome Activation and Astrogliosis
The RFX Complex Is Crucial for the Constitutive and CIITA-Mediated Transactivation of MHC Class I and 2-Microglobulin Genes
Genomic Analyses of PMBL Reveal New Drivers and Mechanisms of Sensitivity to PD-1 Blockade
DCIR2 Cdc2 Dcs and Zbtb32 Restore CD4 T-Cell Tolerance
Downloaded Using the Genomicfeatures Package, and Their Locations Were Extended by 1.5 Kb Upstream to Include Their Promoter Region
The 752Delg26 Mutation in the RFXANK Gene Associated With
Dysregulated Immune System Secondary to Novel Heterozygous Mutation of CIITA Gene Presenting with Recurrent Infections and Syste
MAPK Pathway Mutations in Head and Neck Cancer Affect Immune Microenvironments and Erbb3 Signaling
ZBTB32 Restrains Antibody Responses to Murine Cytomegalovirus Infections, but Not Other Repetitive Challenges Arijita Jash1, You W
Expression of Mhc Ii Genes
Cell Differentiation to Plasma Cells B and MHC Class II Gene Expression
CIITA G-286A Promoter Polymorphism Impairs Monocytes HLA-DR Expression In
CIITA Gene Class II Major Histocompatibility Complex Transactivator
The MHC Class II Transactivator CIITA: Not (Quite) the Odd-One-Out Anymore Among NLR Proteins
Cellular and Molecular Regulation of Innate Inflammatory Responses
Top View
PDF-Document
Novel Variants in CIITA Caused Type II Bare Lymphocyte Syndrome: a Case Report
A Caspase-2-RFXANK Interaction and Its Implication for MHC Class II
Dynamic Regulation of the Class II Transactivator by Posttranslational Modifications
Class II Gene Control Promoter IV: a Novel Mechanism Of
Mice Lacking the Transcription Factor CIITA— a Second Look
Introduction of the CIITA Gene Into Tumor Cells Produces Exosomes with Enhanced Anti-Tumor Effects
A Network Analysis of Chinese Medicine Lianhua-Qingwen Formula
Early Epigenetic Regulation of the Adaptive Immune Response Gene CIITA
Specific Complex Formation Between the Type II Bare Lymphocyte Syndrome-Associated Transactivators CIITA and RFX5
ZBTB32 Restricts the Duration of Memory B Cell Recall Responses Arijita Jash, Yinan Wang, Florian J
DCIR2 Cdc2 Dcs and Zbtb32 Restore CD4 T Cell Tolerance and Inhibit
CIITA Is Not Associated with Risk of Developing Rheumatoid Arthritis
High MHC-II Expression in Epstein–Barr Virus-Associated Gastric
CIITA Transformation Rescues the Apoptotic Function of MHC Class II in Melanoma Cells
CIITA Is a Transcriptional Coactivator That Is Recruited to MHC Class II Promoters by Multiple Synergistic Interactions with an Enhanceosome Complex
Loss of Zbtb32 in NOD Mice Does Not Significantly Alter T Cell Responses
Interferon (IFN)
XPO1 in B Cell Hematological Malignancies
Leading to a Mild Immunodeficiency Activator Trans- Mutation in the Class II
Inflammatory Pathways NLRC5 Limits the Activation Of
Toward a Multiscale Model of Antigen Presentation in Immunity
Direct Genetic Correction As a New Method for Diagnosis and Molecular Characterization of MHC Class II Deficiency
CIITA Activity Through Phosphorylation CIITA
MHC Class I Gene Expression Transcription Factor Complex To
Investigating the Role of the Human Naip/Nlrc4 Inflammasome in Host Defense Against Gram-Negative Bacterial Infection
The NLRC4 Inflammasome and Its Regulation of Liver Disease
Transient Expression of ZBTB32 in Anti-Viral CD8+ T Cells Limits the Magnitude of the Effector Response and the Generation of Memory
Accessibility Differentiation Controls CIITA Promoter Epigenetic
Role of Human Leukocyte Antigen System As a Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients
XPO1 in B Cell Hematological Malignancies
Locus CIITA BRG1 Dependency on the Polycomb Repressive Complex
Specific Complex Formation Between the Type II Bare Lymphocyte Syndrome-Associated Transactivators CIITA and RFX5
Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma
Bare Lymphocyte Syndrome Type II
Manipulation of the MHC Class II Antigen Presentation Pathway
CIITA Promoter I CARD-Deficient Mice Express Functional MHC Class II Genes in Myeloid and Lymphoid Compartments
Signaling Pathways of Genetic Variants and Mirnas in the Pathogenesis of Myasthenia Gravis
Distinct Interferon Signatures Stratify Inflammatory and Dysimmune Myopathies